Abstract
Transthoracic shocks using relatively low energy, for example, less than 40 joules, often can terminate organized sustained ventricular tachycardia. However, transthoracic shocks with these energy levels are painful and not tolerated by the awake patient. Previous investigations by Mirowski et al (1) demonstrated that ventricular fibrillation could be terminated in humans with an implantable defibrillator. We hypothesized that shocks applied directly to the myocardium via a catheter electrode might terminate sustained ventricular tachycardia with even lower energy levels than those used transthoracically or those necessary for internal defibrillation. These well-tolerated shocks would enable cardioversion in the awake alert patient. This report details the development of such a system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Mirowski JF, Reid PR, Mower MM, Watkins L, Gott VL, Schäuble JF, Langer A, Heilman MF, Kolenik SA, Fischeil RE, Weisfeldt ML: Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 303:322–324, 1980.
Jackman WM, Zipes DP: Low-energy synchronous cardioversion of ventricular tachycardia using a catheter electrode in a canine model of subacute myocardial infarction. Circulation 66:187–195, 1982.
Zipes DP, Jackman WM, Heger JJ, Chilson DA, Browne KF, Naccarelli GV, Rahilly GT Jr, Prystowsky EN: Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrode. Am Heart J 103:789–794, 1982.
Zipes DP, Prystowsky EN, Browne KF, Chilson DA, Heger JJ: Additional observations on transvenous cardioversion of recurrent ventricular tachycardia. Am Heart J 104:163–164, 1982.
Prystowsky EN, Heger JJ, Zipes DP: Transvenous cardioversion to treat tachyarrhythmias. In: J Morganroth and EN Moore (eds) Sudden Cardiac Death and Congestive Heart Failure: Diagnosis and Treatment. Martinus Nijhoff, The Hague, 1983, pp 185–198.
Yee R, Zipes DP, Gulamhusein S, Kallok MJ, Klein GJ: Low energy countershock using an intravascular catheter in an acute care setting. Am J Cardiol 50:1124–1129, 1982.
Kallok MJ, Fisher JD, Fletcher RD, Hartzler GO, Kehoe RF, Klein GJ, Prystowsky EN, Ruffy R, Zipes DP: Intracavitary cardioversion and defibrillation — a multicenter study. (Abstract) Circulation 68(111):89, 1983.
Zipes DP, Heger JJ, Miles WM, Mahomed Y, Brown JW, Spielman SR, Prystowsky EN: Early experience with the implantable cardioverter. N Engl J Med 311:485–490, 1984.
Prystowsky EN, Heger JJ, Lloyd EA, Zipes DP: Clinical electrophysi-ology of ventricular tachycardia. In: DP Zipes (ed) Cardiac Arrhythmias. W.B. Saunders Co., Philadelphia, 1983, pp 253–273.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Prystowsky, E.N., Miles, W.M., Heger, J.J., Zipes, D.P. (1985). Termination of Ventricular Tachycardia by Transvenous Cardioversion. In: Morganroth, J., Moore, E.N. (eds) Cardiac Arrhythmias: New Therapeutic Drugs and Devices. Developments in Cardiovascular Medicine, vol 47. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2595-6_17
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2595-6_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9626-3
Online ISBN: 978-1-4613-2595-6
eBook Packages: Springer Book Archive